Get started
Author

Mehreteab Aregay

Comparing INLA and OpenBUGS for hierarchical Poisson modeling in disease mapping
2015 · R. Carroll, A.B. Lawson, et al. · Spatial and Spatio-temporal Epidemiology · 107
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer
2022 · Alberto A. Chiappori, Ben Creelan, et al. · Clinical Cancer Research · 75
PDF
LBA55 Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial
2022 · K. Goto, K. Sang-We, et al. · Annals of Oncology · 60
PDF
Spatial small area smoothing models for handling survey data with nonresponse
2017 · K. Watjou, C. Faes, et al. · Statistics in Medicine · 22
Disease mapping of zero-excessive mesothelioma data in Flanders
2016 · Thomas Neyens, Andrew B. Lawson, et al. · Annals of Epidemiology · 19
Spatio‐temporal Bayesian model selection for disease mapping
2016 · Rachel Carroll, Andrew B. Lawson, et al. · Environmetrics · 19
Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
2021 · Kanwal Pratap Singh Raghav, Takayuki Yoshino, et al. · Journal of Clinical Oncology · 18
Bayesian multi-scale modeling for aggregated disease mapping data
2015 · Mehreteab Aregay, Andrew B Lawson, et al. · Statistical Methods in Medical Research · 18
Spatially-dependent Bayesian model selection for disease mapping
2016 · Rachel Carroll, Andrew B Lawson, et al. · Statistical Methods in Medical Research · 15
Model-Based Estimates of Long-Term Persistence of Induced HPV Antibodies: A Flexible Subject-Specific Approach
2013 · Mehreteab Aregay, Ziv Shkedy, et al. · Journal of Biopharmaceutical Statistics · 15
Phase III, double-blind, placebo-controlled, 2-cohort, randomized study of saruparib (AZD5305) in combination with new hormonal agents in patients with metastatic castration-sensitive prostate cancer with and without homologous recombination repair mutation (EvoPAR-Prostate01).
2024 · Kim N. Chi, Neeraj Agarwal, et al. · Journal of Clinical Oncology · 14
Spatiotemporal multivariate mixture models for Bayesian model selection in disease mapping
2017 · Andrew B. Lawson, Rachel Carroll, et al. · Environmetrics · 14
Space-time variation of respiratory cancers in South Carolina: a flexible multivariate mixture modeling approach to risk estimation
2016 · Rachel Carroll, Andrew B. Lawson, et al. · Annals of Epidemiology · 10
Bayesian multiscale modeling for aggregated disease mapping data
2014 · Mehreteab Aregay, Andrew B. Lawson, et al. · ACM SIGSPATIAL International Workshop on the Use of GIS in Public Health (HealthGIS) · 10
Zero‐inflated multiscale models for aggregated small area health data
2017 · Mehreteab Aregay, Andrew B. Lawson, et al. · Environmetrics · 9
Extensions to Multivariate Space Time Mixture Modeling of Small Area Cancer Data
2017 · Rachel Carroll, Andrew Lawson, et al. · International Journal of Environmental Research and Public Health · 9
PDF
A hierarchical Bayesian approach for the analysis of longitudinal count data with overdispersion: A simulation study
2012 · Mehreteab Aregay, Ziv Shkedy, et al. · Computational Statistics & Data Analysis · 9
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01
2026 · Arun A. Azad, Neeraj Agarwal, et al. · Future Oncology · 8
A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression.
2019 · Daniel E. Castellano, David I. Quinn, et al. · Journal of Clinical Oncology · 8
Spatial mixture multiscale modeling for aggregated health data
2016 · Mehreteab Aregay, Andrew B. Lawson, et al. · Biometrical Journal · 8
Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
2022 · Kanwal Pratap Singh Raghav, Takayuki Yoshino, et al. · Journal of Clinical Oncology · 7
Multiscale measurement error models for aggregated small area health data
2016 · Mehreteab Aregay, Andrew B Lawson, et al. · Statistical Methods in Medical Research · 7
Bayesian model selection methods in modeling small area colon cancer incidence
2015 · Rachel Carroll, Andrew B. Lawson, et al. · Annals of Epidemiology · 7
Impact of Income on Small Area Low Birth Weight Incidence Using Multiscale Models
2015 · Mehreteab Aregay, Andrew B. Lawson, et al. · AIMS Public Health · 6
Phase III, double-blind, placebo-controlled, 2-cohort, randomized study of saruparib (AZD5305) in combination with androgen receptor pathway inhibitors in patients with metastatic hormone-sensitive prostate cancer with and without homologous recombination repair mutation (EvoPAR-Prostate01).
2025 · Arun Azad, Neeraj Agarwal, et al. · Journal of Clinical Oncology · 5
PDF
Works count: 52
Citation count: 516
H-index: 12
I10-index: 14
Year
Topic
Type